Researchers have distinguished the nerve cells in the brain that control the beneficial effects of GLP-1R agonists – such as ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight – without ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight -- without causing nausea.

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight - without causing nausea ...

Weight-loss drugs cannot be a short-term solution and GPs will need to engage with obesity management as the medicines are ...

The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price ...

MEDVi, an online hub for GLP-1 drugs, wants you to know that it's "serious" about helping you lose weight. According to its ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

"Being linked to 'Ozempic face' inducing changes to the mouth, teeth, gums and surrounding facial structures due to the rapid ...